- About
-
Services
-
Offerings
- Offerings
- ADME and Bioanalytical Sciences
- Analytical Chemistry
- Assay Development
- Biochemical Assays
- Biophysical Assays
- Cell Based Assays
- Computational Chemistry
- Fragment and Compound Screening
- Integrated Drug Discovery Services
- Medicinal Chemistry
- Project Management and Consultancy Services
- Protein Expression and Purification Services
- Structural Biology
- Synthetic Chemistry
- Virtual screening
-
Research Phases
- Research Phases
- Hit Identification
- Hit to Lead
- Lead Optimisation
- Therapeutic Areas
- Target Classes
-
Approaches & Techniques
- Approaches & Techniques
- CDH (Target Gene Fragmentation)
- Cryogenic Electron Microscopy (Cryo-EM)
- Differential Scanning Fluorimetry (DSF) and nanoDSF Services
- Direct-to-Biology (D2B)
- Dynamic Light Scattering (DLS)
- eProtein Discovery
- Flow Cytometry
- Fragment Based Drug Discovery (FBDD)
- FragmentBuilder
- Grating-Coupled Interferometry
- High Throughput Screening
- Isothermal Titration Calorimetry (ITC)
- LeadBuilder
- Photoaffinity Labelling
- PoLiPa (Membrane Protein Solubilisation)
- Spectral Shift and MST Services
- Structure Based Drug Design (SBDD)
- Surface Plasmon Resonance (SPR)
- X-ray Crystallography
-
Offerings
- Library
- News & Events
- Careers
BMCS New approaches to the treatment of Parkinson’s
Wednesday, 12 Nov '25
BMCS New approaches to the treatment of Parkinson’s is specifically designed for professionals dedicated to developing new therapeutics for Parkinson’s disease and will highlight current research offering symptomatic relief and disease modifying approaches.
Jonathan Powell (Group Leader, Chemistry) will be giving a talk at this event entitled "Development of C5aR1 negative allosteric modulators with potential benefits for neuroinflammation."
News
Start your next project with Domainex
Contact one of our experts today